Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00184600
Status:
COMPLETED
Last Update Posted:
2017-03-09
First Post:
2005-09-13
Brief Title:
Comparison of Insulin Detemir Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
A 36-month Multi-centre Open-label Randomised Parallel-group Trial Comparing the Safety Efficacy and Durability of Adding a Basal Insulin Versus a Twice Daily Insulin Mixture Versus a Meal-time Rapid-Acting Insulin in Subjects With Type 2 Diabetes Inadequately Controlled on Therapy With Oral Agents and Assessing the Requirement for More Complex Insulin Regimens to Achieve and Maintain Glycaemic Control Their Efficacy and Durability
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
4T
Brief Summary:
This trial is conducted in Europe
The aim of this research study is to compare the efficacy reduction in HbA1c and in blood glucose levels of insulin detemir insulin aspart and biphasic insulin aspart 30 when added to current OAD oral anti-diabetic drug treatment in subjects with type 2 diabetes and to verify the safety of use number and severity of episodes of hypoglycaemia body weight and side effects
The aim of this research study is to compare the efficacy reduction in HbA1c and in blood glucose levels of insulin detemir insulin aspart and biphasic insulin aspart 30 when added to current OAD oral anti-diabetic drug treatment in subjects with type 2 diabetes and to verify the safety of use number and severity of episodes of hypoglycaemia body weight and side effects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-000514-38 | EUDRACT_NUMBER | None | None |